-
1
-
-
0025105218
-
Competitive and non-competitive NMDA antagonists limit dynorphin A-induced rat hind limb paralysis
-
Bakshi R., and Faden A.I. Competitive and non-competitive NMDA antagonists limit dynorphin A-induced rat hind limb paralysis. Brain Res 507 (1990) 1-5
-
(1990)
Brain Res
, vol.507
, pp. 1-5
-
-
Bakshi, R.1
Faden, A.I.2
-
2
-
-
0029950199
-
14C]-gamma-aminobutyric acid from rat brain synaptosomes
-
14C]-gamma-aminobutyric acid from rat brain synaptosomes. Life Sci 58 (1996) 447-454
-
(1996)
Life Sci
, vol.58
, pp. 447-454
-
-
Bartlett, S.E.1
Smith, M.T.2
-
4
-
-
0028017873
-
Pharmacology of morphine and morphine-3-glucuronide at opioid, excitatory amino acid, GABA and glycine binding sites
-
Bartlett S.E., Dodd P.R., and Smith M.T. Pharmacology of morphine and morphine-3-glucuronide at opioid, excitatory amino acid, GABA and glycine binding sites. Pharmacol Toxicol 75 (1994) 73-81
-
(1994)
Pharmacol Toxicol
, vol.75
, pp. 73-81
-
-
Bartlett, S.E.1
Dodd, P.R.2
Smith, M.T.3
-
5
-
-
0020516360
-
Dynorphin induces partially reversible paraplegia in the rat
-
Faden A.I., and Jacobs T.P. Dynorphin induces partially reversible paraplegia in the rat. Eur J Pharmacol 91 (1983) 321-324
-
(1983)
Eur J Pharmacol
, vol.91
, pp. 321-324
-
-
Faden, A.I.1
Jacobs, T.P.2
-
6
-
-
0021340404
-
Dynorphin-related peptides cause motor dysfunction in the rat through a non-opiate action
-
Faden A.I., and Jacobs T.P. Dynorphin-related peptides cause motor dysfunction in the rat through a non-opiate action. Br J Pharmac 81 (1984) 271-276
-
(1984)
Br J Pharmac
, vol.81
, pp. 271-276
-
-
Faden, A.I.1
Jacobs, T.P.2
-
7
-
-
0033522846
-
Brain region-specific studies of the excitatory behavioral effects of morphine-3-glucuronide
-
Halliday A.J., Bartlett S.E., Colditz P., and Smith M.T. Brain region-specific studies of the excitatory behavioral effects of morphine-3-glucuronide. Life Sci 65 (1999) 225-236
-
(1999)
Life Sci
, vol.65
, pp. 225-236
-
-
Halliday, A.J.1
Bartlett, S.E.2
Colditz, P.3
Smith, M.T.4
-
8
-
-
0042463635
-
Morphine-3-glucuronide's neuro-excitatory effects are mediated via indirect activation of N-methyl-d-aspartic acid receptors: mechanistic studies in embryonic cultured hippocampal neurones
-
Hemstapat K., Monteith G.R., Smith D., and Smith M.T. Morphine-3-glucuronide's neuro-excitatory effects are mediated via indirect activation of N-methyl-d-aspartic acid receptors: mechanistic studies in embryonic cultured hippocampal neurones. Anesth Analg 97 (2003) 494-505
-
(2003)
Anesth Analg
, vol.97
, pp. 494-505
-
-
Hemstapat, K.1
Monteith, G.R.2
Smith, D.3
Smith, M.T.4
-
9
-
-
0025758545
-
Species difference of site-selective glucuronidation of morphine
-
Kuo C.K., Hanioka N., Hoshikawa Y., Oguri K., and Yoshimura H. Species difference of site-selective glucuronidation of morphine. J Pharmacobio-Dyn 14 (1991) 187-193
-
(1991)
J Pharmacobio-Dyn
, vol.14
, pp. 187-193
-
-
Kuo, C.K.1
Hanioka, N.2
Hoshikawa, Y.3
Oguri, K.4
Yoshimura, H.5
-
10
-
-
0032524331
-
Dynorphin uses a non-opioid mechanism to potentiate N-methyl-d-aspartate currents in single rat periaqueductal gray neurons
-
Lai S.L., Gu Y., and Huang L.M. Dynorphin uses a non-opioid mechanism to potentiate N-methyl-d-aspartate currents in single rat periaqueductal gray neurons. Neurosci Lett 247 (1998) 115-118
-
(1998)
Neurosci Lett
, vol.247
, pp. 115-118
-
-
Lai, S.L.1
Gu, Y.2
Huang, L.M.3
-
11
-
-
0030879183
-
Spinally administered dynorphin A produces long-lasting allodynia: involvement of NMDA but not opioid receptors
-
Laughlin T.M., Vanderah T.W., Lashbrook J., Nichols M.L., Ossipov M., Porreca F., et al. Spinally administered dynorphin A produces long-lasting allodynia: involvement of NMDA but not opioid receptors. Pain 72 (1997) 253-260
-
(1997)
Pain
, vol.72
, pp. 253-260
-
-
Laughlin, T.M.1
Vanderah, T.W.2
Lashbrook, J.3
Nichols, M.L.4
Ossipov, M.5
Porreca, F.6
-
12
-
-
0034193926
-
Extraterritorial neuropathic pain correlates with multisegmental elevation of spinal dynorphin in nerve-injured rats
-
Malan T.P., Ossipov M.H., Gardell L.R., Ibrahim M., Di B., Lai J., et al. Extraterritorial neuropathic pain correlates with multisegmental elevation of spinal dynorphin in nerve-injured rats. Pain 86 (2000) 185-194
-
(2000)
Pain
, vol.86
, pp. 185-194
-
-
Malan, T.P.1
Ossipov, M.H.2
Gardell, L.R.3
Ibrahim, M.4
Di, B.5
Lai, J.6
-
13
-
-
0035983810
-
Morphine-3β-d-glucuronide suppresses inhibitory synaptic transmission in rat substantia gelatinosa
-
Moran T.D., and Smith P.A. Morphine-3β-d-glucuronide suppresses inhibitory synaptic transmission in rat substantia gelatinosa. J Pharmacol Exp Ther 302 (2002) 568-575
-
(2002)
J Pharmacol Exp Ther
, vol.302
, pp. 568-575
-
-
Moran, T.D.1
Smith, P.A.2
-
14
-
-
0025190756
-
Morphine and metabolite behaviour after different routes of morphine administration: demonstration of the importance of the active metabolite morphine-6-glucuronide
-
Osborne R., Joel S., Trew D., and Slevin M. Morphine and metabolite behaviour after different routes of morphine administration: demonstration of the importance of the active metabolite morphine-6-glucuronide. Clin Pharmacol Ther 47 (1990) 12-19
-
(1990)
Clin Pharmacol Ther
, vol.47
, pp. 12-19
-
-
Osborne, R.1
Joel, S.2
Trew, D.3
Slevin, M.4
-
15
-
-
0023620266
-
Morphine-6-glucuronide, a potent mu agonist
-
Pasternak G.W., Bodnar R.J., Clark J.A., and Inturrisi C.E. Morphine-6-glucuronide, a potent mu agonist. Life Sci 41 (1987) 2845-2849
-
(1987)
Life Sci
, vol.41
, pp. 2845-2849
-
-
Pasternak, G.W.1
Bodnar, R.J.2
Clark, J.A.3
Inturrisi, C.E.4
-
17
-
-
0025922020
-
NMDA receptor antagonists suppress behaviours but not norepinephrine turnover or locus coeruleus unit activity induced by opiate withdrawal
-
Rasmussen K., Fuller R.W., Stockton M.E., Perry K.W., Swinford R.M., and Ornstein P.L. NMDA receptor antagonists suppress behaviours but not norepinephrine turnover or locus coeruleus unit activity induced by opiate withdrawal. Eur J Pharmacol 197 (1991) 9-16
-
(1991)
Eur J Pharmacol
, vol.197
, pp. 9-16
-
-
Rasmussen, K.1
Fuller, R.W.2
Stockton, M.E.3
Perry, K.W.4
Swinford, R.M.5
Ornstein, P.L.6
-
18
-
-
0022627065
-
High-dose morphine and methadone in cancer patients: clinical pharmacokinetic considerations of oral treatment
-
Sawe J. High-dose morphine and methadone in cancer patients: clinical pharmacokinetic considerations of oral treatment. Clin Pharmacokinet 11 (1986) 87-106
-
(1986)
Clin Pharmacokinet
, vol.11
, pp. 87-106
-
-
Sawe, J.1
-
19
-
-
0026640581
-
Selective involvement of kappa opioid and phencyclidine receptors in the analgesic and motor effects of dynorphin-A-(1-13)-Tyr-Leu-Phe-Asn-Gly-Pro
-
Shukla V.K., Bansinath M., Dumont M., and Lemaire S. Selective involvement of kappa opioid and phencyclidine receptors in the analgesic and motor effects of dynorphin-A-(1-13)-Tyr-Leu-Phe-Asn-Gly-Pro. Brain Res 591 (1992) 176-180
-
(1992)
Brain Res
, vol.591
, pp. 176-180
-
-
Shukla, V.K.1
Bansinath, M.2
Dumont, M.3
Lemaire, S.4
-
20
-
-
0030783867
-
Nonopioid motor effects of dynorphin A and related peptides: structure dependence and role of the N-methyl-d-aspartate receptor
-
Shukla V.K., Prasad J.A., and Lemaire S. Nonopioid motor effects of dynorphin A and related peptides: structure dependence and role of the N-methyl-d-aspartate receptor. J Pharmacol Exp Therap 283 (1997) 604-609
-
(1997)
J Pharmacol Exp Therap
, vol.283
, pp. 604-609
-
-
Shukla, V.K.1
Prasad, J.A.2
Lemaire, S.3
-
21
-
-
0034053670
-
Neuroexcitatory effects of morphine and hydromorphone: evidence implicating the 3-glucuronide metabolites
-
Smith M.T. Neuroexcitatory effects of morphine and hydromorphone: evidence implicating the 3-glucuronide metabolites. Clin Exp Pharmacol Physiol 27 (2000) 524-528
-
(2000)
Clin Exp Pharmacol Physiol
, vol.27
, pp. 524-528
-
-
Smith, M.T.1
-
22
-
-
0022460723
-
Dynorphin A and related peptides administered intrathecally in the rat: a search for putative kappa opiate receptor activity
-
Stevens C.W., and Yaksh T.L. Dynorphin A and related peptides administered intrathecally in the rat: a search for putative kappa opiate receptor activity. J Pharmacol Exp Ther 238 (1986) 833-838
-
(1986)
J Pharmacol Exp Ther
, vol.238
, pp. 833-838
-
-
Stevens, C.W.1
Yaksh, T.L.2
-
23
-
-
0027374701
-
Intrathecal morphine-3-glucuronide does not antagonize spinal antinociception by morphine or morphine-6-glucuronide in rats
-
Suzuki N., Kalso E., and Rosenberg P.H. Intrathecal morphine-3-glucuronide does not antagonize spinal antinociception by morphine or morphine-6-glucuronide in rats. Eur J Pharmacol 249 (1993) 247-250
-
(1993)
Eur J Pharmacol
, vol.249
, pp. 247-250
-
-
Suzuki, N.1
Kalso, E.2
Rosenberg, P.H.3
-
24
-
-
0032741184
-
High-affinity interaction of (des-Tyrosyl)dynorphin A(2-17) with NMDA receptors
-
Tang Q., Gandhoke R., Burritt A., Hruby V.J., Porreca F., and Lai J. High-affinity interaction of (des-Tyrosyl)dynorphin A(2-17) with NMDA receptors. J Pharmacol Exp Ther 291 (1999) 760-765
-
(1999)
J Pharmacol Exp Ther
, vol.291
, pp. 760-765
-
-
Tang, Q.1
Gandhoke, R.2
Burritt, A.3
Hruby, V.J.4
Porreca, F.5
Lai, J.6
-
25
-
-
17344385566
-
Single intrathecal injections of dynorphin A or des-Tyr-dynorphins produce long-lasting allodynia in rats: blockade by MK-801 but not naloxone
-
Vanderah T.W., Laughlin T., Lashbrook J.M., Nichols M.L., Wilcox G.L., Ossipov M.H., et al. Single intrathecal injections of dynorphin A or des-Tyr-dynorphins produce long-lasting allodynia in rats: blockade by MK-801 but not naloxone. Pain 68 (1996) 275-281
-
(1996)
Pain
, vol.68
, pp. 275-281
-
-
Vanderah, T.W.1
Laughlin, T.2
Lashbrook, J.M.3
Nichols, M.L.4
Wilcox, G.L.5
Ossipov, M.H.6
-
26
-
-
0020467840
-
Nonopiate effects of dynorphin and des-tyr-dynorphin
-
Walker J.M., Moises H.C., Coy D.H., Baldrighi G., and Akil H. Nonopiate effects of dynorphin and des-tyr-dynorphin. Science 218 (1982) 1136-1138
-
(1982)
Science
, vol.218
, pp. 1136-1138
-
-
Walker, J.M.1
Moises, H.C.2
Coy, D.H.3
Baldrighi, G.4
Akil, H.5
-
27
-
-
0020364689
-
Dynorphin (1-17): lack of analgesia but evidence for non-opiate electrophysiological and motor effects
-
Walker J.M., Moises H.C., Coy D.H., Young E.A., Watson S.J., and Akil H. Dynorphin (1-17): lack of analgesia but evidence for non-opiate electrophysiological and motor effects. Life Sci 31 (1982) 1821-1824
-
(1982)
Life Sci
, vol.31
, pp. 1821-1824
-
-
Walker, J.M.1
Moises, H.C.2
Coy, D.H.3
Young, E.A.4
Watson, S.J.5
Akil, H.6
-
28
-
-
0019524261
-
Intrathecal high dose morphine produces hyperalgesia in the rat
-
Woolf C.J. Intrathecal high dose morphine produces hyperalgesia in the rat. Brain Res 209 (1981) 491-495
-
(1981)
Brain Res
, vol.209
, pp. 491-495
-
-
Woolf, C.J.1
-
29
-
-
0035876325
-
Hydromorphone-3-glucuronide: a more potent neuro-excitant than its structural analogue, morphine-3-glucuronide
-
Wright A.W.E., Mather L.E., and Smith M.T. Hydromorphone-3-glucuronide: a more potent neuro-excitant than its structural analogue, morphine-3-glucuronide. Life Sci 69 (2001) 409-420
-
(2001)
Life Sci
, vol.69
, pp. 409-420
-
-
Wright, A.W.E.1
Mather, L.E.2
Smith, M.T.3
-
30
-
-
0023829817
-
Pharmacology of the allodynia in rats evoked by high dose intrathecal morphine
-
Yaksh T.L., and Harty G.J. Pharmacology of the allodynia in rats evoked by high dose intrathecal morphine. J Pharmacol Exp Ther 244 (1988) 501-507
-
(1988)
J Pharmacol Exp Ther
, vol.244
, pp. 501-507
-
-
Yaksh, T.L.1
Harty, G.J.2
-
31
-
-
0023186731
-
The degradation of dynorphin A in brain tissue in vivo and in vitro
-
Young E.A., Walker J.M., Houghten R., and Akil H. The degradation of dynorphin A in brain tissue in vivo and in vitro. Peptides 8 (1987) 701-707
-
(1987)
Peptides
, vol.8
, pp. 701-707
-
-
Young, E.A.1
Walker, J.M.2
Houghten, R.3
Akil, H.4
-
32
-
-
0031871146
-
Dynorphin A as a potential endogenous ligand for four members of the opioid receptor gene family
-
Zhang S., Tong Y., Tian M., Dehaven R.N., Cortesburgos L., Mansson E., et al. Dynorphin A as a potential endogenous ligand for four members of the opioid receptor gene family. J Pharmacol Exp Ther 286 (1998) 136-141
-
(1998)
J Pharmacol Exp Ther
, vol.286
, pp. 136-141
-
-
Zhang, S.1
Tong, Y.2
Tian, M.3
Dehaven, R.N.4
Cortesburgos, L.5
Mansson, E.6
|